#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4476933	B	Inhibition of C-terminal FLAG-6x-His epitope tagged and N-terminal human RAGE signal sequence tagged human BMP1 (23 to 721 amino acids) expressed in CHO-E1 cells pre-incubated for 10 mins before promyostatin peptide substrate addition and measured after 60 mins using 0.5 nM BMP1 by FRET based assay	Homo sapiens	148		cell-based format	Patent Bioactivity Data
2.	ALA4476934	B	Inhibition of C-terminal FLAG-6x-His epitope tagged and N-terminal human RAGE signal sequence tagged human BMP1 (23 to 721 amino acids) expressed in CHO-E1 cells pre-incubated for 10 mins before promyostatin peptide substrate addition and measured after 30 mins using 50 nM BMP1 by FRET based assay	Homo sapiens	146		cell-based format	Patent Bioactivity Data
3.	ALA4476935	B	Inhibition of recombinant human TLL1 I156V/N221S/V284A mutant expressed in CHOE1A cells pre-incubated for 10 mins before promyostatin peptide substrate addition and measured after 60 mins by FRET based assay	Homo sapiens	141		cell-based format	Patent Bioactivity Data
4.	ALA4476936	B	Inhibition of C-terminal Avi-6x-His epitope tagged and N-terminal human RAGE signal sequence tagged recombinant human TLL2 (26 to 1015 amino acids) expressed in CHOE1A cells incubated for 60 mins with promyostatin peptide substrate by FRET based assay	Homo sapiens	139		cell-based format	Patent Bioactivity Data
5.	ALA4476937	F	Reduction in PICP levels in human cardiac fibroblasts incubated for 24 to 48 hrs by ELISA	Homo sapiens	112		assay format	Patent Bioactivity Data
6.	ALA4476938	F	Reduction in mature collagen deposition levels in human cardiac fibroblasts incubated for 24 to 48 hrs by immunostaining based assay	Homo sapiens	27		assay format	Patent Bioactivity Data